Copyright © 2009 Yixia Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L.-H. Tsai, T. Takahashi, V. S. Caviness Jr., and E. Harlow, “Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system,” Development, vol. 119, no. 4, pp. 1029–1040, 1993.
2. J. Lew, R. J. Winkfein, H. K. Paudel, and J. H. Wang, “Brain proline-directed protein kinase is a neurofilament kinase which displays high sequence homology to p34cdc2,” The Journal of Biological Chemistry, vol. 267, no. 36, pp. 25922–25926, 1992.
3. F. A. Dhariwala and M. S. Rajadhyaksha, “An unusual member of the Cdk family: Cdk5,” Cellular and Molecular Neurobiology, vol. 28, no. 3, pp. 351–369, 2008. View at Publisher · View at Google Scholar · View at PubMed
4. Y. Hirota, T. Ohshima, N. Kaneko, et al., “Cyclin-dependent kinase 5 is required for control of neuroblast migration in the postnatal subventricular zone,” Journal of Neuroscience, vol. 27, no. 47, pp. 12829–12838, 2007. View at Publisher · View at Google Scholar · View at PubMed
5. L. Connell-Crowley, M. Le Gall, D. J. Vo, and E. Giniger, “The cyclin-dependent kinase Cdk5 controls multiple aspects of axon patterning in vivo,” Current Biology, vol. 10, no. 10, pp. 599–602, 2000. View at Publisher · View at Google Scholar
6. S. Rakić, C. Davis, Z. Molnár, M. Nikolić, and J. G. Parnavelas, “Role of p35/Cdk5 in preplate splitting in the developing cerebral cortex,” Cerebral Cortex, vol. 16, supplement 1, pp. i35–i45, 2006.
7. J. L. Rosales, J. D. Ernst, J. Hallows, and K.-Y. Lee, “GTP-dependent secretion from neutrophils is regulated by Cdk5,” The Journal of Biological Chemistry, vol. 279, no. 52, pp. 53932–53936, 2004. View at Publisher · View at Google Scholar · View at PubMed
8. R. Homayouni and T. Curran, “Cortical development: Cdk5 gets into sticky situations,” Current Biology, vol. 10, no. 9, pp. R331–R334, 2000. View at Publisher · View at Google Scholar
9. Y. Miyamoto, J. Yamauchi, J. R. Chan, et al., “Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin,” Journal of Cell Science, vol. 120, no. 24, pp. 4355–4366, 2007. View at Publisher · View at Google Scholar · View at PubMed
10. A. H. Hawasli and J. A. Bibb, “Alternative roles for Cdk5 in learning and synaptic plasticity,” Biotechnology Journal, vol. 2, no. 8, pp. 941–948, 2007. View at Publisher · View at Google Scholar · View at PubMed
11. X. Xin, F. Ferraro, N. Bäck, B. A. Eipper, and R. E. Mains, “Cdk5 and Trio modulate endocrine cell exocytosis,” Journal of Cell Science, vol. 117, no. 20, pp. 4739–4748, 2004. View at Publisher · View at Google Scholar · View at PubMed
12. E.-A. Choe, L. Liao, J.-Y. Zhou, et al., “Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1,” Journal of Neuroscience, vol. 27, no. 35, pp. 9503–9512, 2007. View at Publisher · View at Google Scholar · View at PubMed
13. Y. Feng and C. A. Walsh, “Protein-protein interactions, cytoskeletal regulation and neuronal migration,” Nature Reviews Neuroscience, vol. 2, no. 6, pp. 408–416, 2001. View at Publisher · View at Google Scholar · View at PubMed
14. J. C. Cruz and L.-H. Tsai, “Cdk5 deregulation in the pathogenesis of Alzheimer's disease,” Trends in Molecular Medicine, vol. 10, no. 9, pp. 452–458, 2004. View at Publisher · View at Google Scholar · View at PubMed
15. Q. Guo, “When good Cdk5 turns bad,” Science of Aging Knowledge Environment, vol. 2006, no. 5, article pe5, 2006. View at Publisher · View at Google Scholar · View at PubMed
16. J. Zhang and G. V. W. Johnson, “Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells,” Journal of Neurochemistry, vol. 75, no. 6, pp. 2346–2357, 2000. View at Publisher · View at Google Scholar
17. Q. Zhang, H. S. Ahuja, Z. Zakeri, and D. J. Wolgemuth, “Cyclin-dependent kinase 5 is associated with apoptotic cell death during development and tissue remodeling,” Developmental Biology, vol. 183, no. 2, pp. 222–233, 1997. View at Publisher · View at Google Scholar · View at PubMed
18. Z. H. Cheung, A. K. Y. Fu, and N. Y. Ip, “Synaptic roles of Cdk5: implications in higher cognitive functions and neurodegenerative diseases,” Neuron, vol. 50, no. 1, pp. 13–18, 2006. View at Publisher · View at Google Scholar · View at PubMed
19. T. Sandal, C. Stapnes, H. Kleivdal, L. Hedin, and S. O. Døskeland, “A novel, extraneuronal role for cyclin-dependent protein kinase 5 (CDK5): modulation of cAMP-induced apoptosis in rat leukemia cells,” The Journal of Biological Chemistry, vol. 277, no. 23, pp. 20783–20793, 2002. View at Publisher · View at Google Scholar · View at PubMed
20. Y. Zhu, L. Lin, S. Kim, D. Quaglino, R. A. Lockshin, and Z. Zakeri, “Cyclin dependent kinase 5 and its interacting proteins in cell death induced in vivo by cyclophosphamide in developing mouse embryos,” Cell Death and Differentiation, vol. 9, no. 4, pp. 421–430, 2002. View at Publisher · View at Google Scholar
21. J. L. Rosales and K.-Y. Lee, “Extraneuronal roles of cyclin-dependent kinase 5,” BioEssays, vol. 28, no. 10, pp. 1023–1034, 2006. View at Publisher · View at Google Scholar · View at PubMed
22. A. K. Upadhyay, A. K. Ajay, S. Singh, and M. K. Bhat, “Cell cycle regulatory protein 5 (cdk5) is a novel downstream target of ERK in carboplatin induced death of breast cancer cells,” Current Cancer Drug Targets, vol. 8, no. 8, pp. 741–752, 2008. View at Publisher · View at Google Scholar
23. H. S. Ahuja, W. James, and Z. Zakeri, “Rescue of the limb deformity in hammertoe mutant mice by retinoic acid-induced cell death,” Developmental Dynamics, vol. 208, no. 4, pp. 466–481, 1997. View at Publisher · View at Google Scholar
24. F. Gao, U. Jütting, K. Rodenacker, P. Gais, and P.-Z. Lin, “Relevance of chromatin features in the progression of esophageal epithelial severe dysplasia,” Analytical Cellular Pathology, vol. 13, no. 1, pp. 17–28, 1997.
25. L. Lin, Y. Ye, and Z. Zakeri, “P53, Apaf-1, caspase-3, and -9 are dispensable for Cdk5 activation during cell death,” Cell Death and Differentiation, vol. 13, no. 1, pp. 141–150, 2006. View at Publisher · View at Google Scholar · View at PubMed
26. L. Cagnon and O. Braissant, “Role of caspases, calpain and cdk5 in ammonia-induced cell death in developing brain cells,” Neurobiology of Disease, vol. 32, no. 2, pp. 281–292, 2008. View at Publisher · View at Google Scholar · View at PubMed
27. M. Slevin and J. Krupinski, “Cyclin-dependent kinase-5 targeting for ischaemic stroke,” Current Opinion in Pharmacology, vol. 9, no. 2, pp. 119–124, 2009. View at Publisher · View at Google Scholar · View at PubMed
28. P. Paoletti, I. Vila, M. Rifé, J. M. Lizcano, J. Alberch, and S. Ginés, “Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5,” Journal of Neuroscience, vol. 28, no. 40, pp. 10090–10101, 2008. View at Publisher · View at Google Scholar · View at PubMed
29. L.-H. Teai, I. Delalle, V. S. Cavness Jr., T. Chae, and E. Harlow, “p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5,” Nature, vol. 371, no. 6496, pp. 419–423, 1994. View at Publisher · View at Google Scholar · View at PubMed
30. D. Tang, J. Yeung, K.-Y. Lee, et al., “An isoform of the neuronal cyclin-dependent kinase 5 (Cdk5) activator,” The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26897–26903, 1995. View at Publisher · View at Google Scholar
31. R. Donnellan and R. Chetty, “Cyclin E in human cancers,” The FASEB Journal, vol. 13, no. 8, pp. 773–780, 1999.
32. A. Dinarina, L. H. Perez, A. Davila, M. Schwab, T. Hunt, and A. R. Nebreda, “Characterization of a new family of cyclin-dependent kinase activators,” Biochemical Journal, vol. 386, no. 2, pp. 349–355, 2005.
33. D. I. Orellana, R. A. Quintanilla, and R. B. Maccioni, “Neuroprotective effect of TNF$\alpha$ against the $\beta$-amyloid neurotoxicity mediated by CDK5 kinase,” Biochimica et Biophysica Acta, vol. 1773, no. 2, pp. 254–263, 2007. View at Publisher · View at Google Scholar · View at PubMed
34. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at Publisher · View at Google Scholar
35. K.-H. Sun, Y. de Pablo, F. Vincent, and K. Shah, “Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction,” Journal of Neurochemistry, vol. 107, no. 1, pp. 265–278, 2008. View at Publisher · View at Google Scholar · View at PubMed
36. E. J. Morris, E. Keramaris, H. J. Rideout, et al., “Cyclin-dependent kinases and p53 pathways are activated independently and mediate Bax activation in neurons after DNA damage,” Journal of Neuroscience, vol. 21, no. 14, pp. 5017–5026, 2001.
37. A. R. Nebreda, “CDK activation by non-cyclin proteins,” Current Opinion in Cell Biology, vol. 18, no. 2, pp. 192–198, 2006. View at Publisher · View at Google Scholar · View at PubMed
38. T. Hayashi, M. Sakurai, K. Abe, and Y. Itoyama, “DNA fragmentation precedes aberrant expression of cell cycle-related protein in rat brain after MCA occlusion,” Neurological Research, vol. 21, no. 7, pp. 695–698, 1999.
39. B.-S. Li, L. Zhang, S. Takahashi, et al., “Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3,” The EMBO Journal, vol. 21, no. 3, pp. 324–333, 2002. View at Publisher · View at Google Scholar · View at PubMed
40. J. H. Weishaupt, L. Kussmaul, P. Grötsch, et al., “Inhibition of CDK5 is protective in necrotic and apoptotic paradigms of neuronal cell death and prevents mitochondrial dysfunction,” Molecular and Cellular Neuroscience, vol. 24, no. 2, pp. 489–502, 2003. View at Publisher · View at Google Scholar